Company news
Renalytix PLC news in 2026
Renalytix PLC's news releases, calls and decks from 2026, newest first.
Holding(s) in Company
October 28, 2026
Unaudited Twelve Months to 30 June 2026 Report
October 28, 2026
US Kidney Care National Plan
October 22, 2026
Holding(s) in Company
October 19, 2026
Holding(s) in Company
October 5, 2026
Director/PDMR Shareholding (Replacement)
October 2, 2026
Holding(s) in Company
October 2, 2026
Holding(s) in Company
October 1, 2026
Director/PDMR Shareholding
October 1, 2026
Holding(s) in Company
October 1, 2026
Holding(s) in Company
September 30, 2026
Result of GM
September 28, 2026
Investor Presentations
September 25, 2026
Additional CEO Share Purchase
September 16, 2026
New Accounting Ref Date
September 14, 2026
CEO Share Purchase
September 11, 2026
Posting of Circular and Notice of AGM
September 8, 2026
WRAP Retail Offer for up to £1,000,000
September 3, 2026
Capital Access Window - Renalytix plc
September 1, 2026
AIM Rule 17 Disclosure
August 24, 2026
KidneyIntelX® Delivers Unprecedented Two-Year Real-World Outcomes in Diabetic Kidney Disease: No Comparable Risk Assessment Tool Exists
June 30, 2026
Renalytix™ and Carna Health Partner to Solve Kidney Disease Crisis: Bridging the Existing Gap Between Population Screening and Precision Intervention
May 12, 2026
Key milestones achieved for kidneyintelX.dkd
April 22, 2026
Holding(s) in Company
April 16, 2026
Half-year Report
March 26, 2026
Further CEO Share Purchase
February 13, 2026
Director/PDMR Share Purchase
February 12, 2026
H1 Trading update
February 11, 2026
Three kidneyintelX.dkd Clinical Integrations
January 12, 2026
Calls in 2026
- Renalytix (LSE:RENX) — Company Update
Sep 29, 2026
Transcript